Daily Archives: August 8, 2020

Greek Island Locks Down as COVID-19 Infections Soar Across Country

  ATHENS, GREECE – Three months after easing nationwide restrictions to stem the spread of the coronavirus, the government in Athens has placed the tiny Greek island of Poros into fresh lockdown following a sudden flare-up of infections in scores of locals and tourists. The lockdown comes as the coronavirus pandemic spreads rapidly in Greece,

Virus Resistant: World’s Longest Yard Sale Still Lines US Roads

GADSDEN, ALABAMA – For decades, thousands of vendors have fanned out along roadsides from Alabama to Michigan each summer to haggle over the prices of old Coca-Cola bottles, clothes, toys, knives and more at The World’s Longest Yard Sale. And though the coronavirus pandemic has canceled events around the globe, the six-state yard sale is

Twitter Expressed Interest in Buying TikTok’s US Operations, Sources Say

Twitter Inc has approached TikTok’s Chinese owner ByteDance to express interest in acquiring the U.S. operations of the video-sharing app, two people familiar with the matter told Reuters, as experts raised doubts over Twitter’s ability to put together financing for a potential deal. It is far from certain that Twitter would be able to outbid

Première biopsie liquide à recevoir l’approbation de la FDA pour le profilage complet des tumeurs dans tous les cancers solides, le diagnostic compagnon Guardant360® de Guardant Health gagne en crédibilité auprès des oncologues en Asie, au Moyen-Orient et en Afrique.

SINGAPOUR, 8 août 2020 /PRNewswire/ — La Food and Drug Administration (FDA) des États-Unis a approuvé la biopsie liquide de Guardant Health, le diagnostic compagnon Guardant360®, pour le profilage des mutations tumorales chez les patients atteints de toutes sortes de cancers solides. Pour Guardant Health Asia, Middle East and Africa (AMEA), cette approbation de la FDA […]

First liquid biopsy to receive FDA Approval for comprehensive tumor profiling across all solid cancers, Guardant Health’s Guardant360® CDx, gains credibility among oncologists in Asia, Middle East and Africa.

SINGAPORE, Aug. 8, 2020 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Guardant Health’s liquid biopsy, Guardant360® CDx, for tumor mutation profiling in patients across all solid cancers. For Guardant Health Asia, Middle East and Africa (AMEA), this FDA approval represents a landmark achievement for the Guardant360 test. Currently, the liquid biopsy is […]